Toxic nodular goiter involves an enlarged thyroid gland. The gland contains areas that have increased in size and formed nodules. One or more of these nodules produce too much thyroid hormone.
Toxic nodular goiter starts from an existing simple goiter. It occurs most often in older adults. Risk factors include being female and over 55 years old. This disorder is rare in children. Most people who develop it have had a goiter with nodules for many years.
Sometimes, people with toxic multinodular goiter will develop high thyroid levels for the first time. This mostly occurs after they take in a large amount of iodine through a vein (intravenously) or by mouth. The iodine may be used as contrast for a CT scan or heart catheterization. Taking medicines that contain iodine, such as amiodarone, may also lead to the disorder. Moving from a country with iodine deficiency to a country with a lot of iodine in the diet can also turn a simple goiter into a toxic goiter.
Symptoms may include any of the following:
- Frequent bowel movements
- Heat intolerance
- Increased appetite
- Increased sweating
- Irregular menstrual period (in women)
- Muscle cramps
- Weight loss
Older adults may have symptoms that are less specific. These may include weakness and fatigue, palpitations and chest pain or pressure, and changes in memory and mood.
Toxic nodular goiter does not cause the bulging eyes that can occur with Graves disease. This is an autoimmune disorder that leads to an overactive thyroid gland (hyperthyroidism).
Exams and Tests
Beta-blockers (propranolol) can control some of the symptoms of hyperthyroidism until thyroid hormone levels in the body are under control.
Certain drugs can block or change how the thyroid gland uses iodine. These drugs may be used to control the overactive thyroid gland in any of the following cases:
- Before surgery or radioiodine therapy occurs
- As a long term treatment
Radioiodine therapy may be used. Radioactive iodine is given by mouth. It then concentrates in the overactive thyroid tissue and causes damage. In rare cases, thyroid replacement is needed afterward.
Surgery to remove the thyroid may be done when:
- Very large goiter or a goiter is causing symptoms by making it hard to breathe or swallow
- Thyroid cancer is present
- Rapid treatment is needed
Toxic nodular goiter is mainly a disease of older adults, so other chronic health problems may affect the outcome of this condition. An older adult may be less able to tolerate the effect of the disease on the heart. However, the condition is often treatable with medicines.
- Bone loss leading to osteoporosis
Thyroid crisis or storm is an acute worsening of hyperthyroidism symptoms. It may occur with infection or stress. Thyroid crisis may cause:
- Abdominal pain
- Decreased mental alertness
People with this condition need to go to the hospital right away.
Complications of having a very large goiter may include difficulty breathing or swallowing. These complications are due to pressure on the airway passage (trachea) or esophagus, which lies behind the thyroid.
When to Contact a Medical Professional
Call your provider if you have symptoms of this disorder. Follow the provider's instructions for follow-up visits.
To prevent toxic nodular goiter, treat hyperthyroidism and simple goiter as your provider suggests.
Toxic multinodular goiter; Plummer disease; Thyrotoxicosis - nodular goiter; Overactive thyroid - toxic nodular goiter; Hyperthyroidism - toxic nodular goiter; Toxic multinodular goiter; MNG
Hegedus L, Paschke R, Krohn K, Bonnema SJ. Multinodular goiter. In: Jameson JL, De Groot LJ, de Kretser DM, et al, eds. Endocrinology: Adult and Pediatric. 7th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 90.
Kim M, Ladenson PW. Thyroid. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 25th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 226.
Kopp P. Autonomously functioning thyroid nodules and other causes of thyrotoxicosis. In: Jameson JL, De Groot LJ, de Kretser DM, et al, eds. Endocrinology: Adult and Pediatric. 7th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 85.
Review Date 2/22/2018
Updated by: Brent Wisse, MD, Associate Professor of Medicine, Division of Metabolism, Endocrinology & Nutrition, University of Washington School of Medicine, Seattle, WA. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.